The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2023
Filed:
Oct. 17, 2022
Applicant:
Intas Pharmaceuticals Ltd., Ahmedabad, IN;
Inventors:
Mayank Saxena, Ahmedabad, IN;
Rikin Patel, Ahmedabad, IN;
Piyush Kansagra, Ahmedabad, IN;
Balvir Singh, Ahmedabad, IN;
Ashish Sehgal, Ahmedabad, IN;
Assignee:
INTAS PHARMACEUTICALS LTD., Ahmedabad, IN;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A61K 9/20 (2006.01); A61K 9/51 (2006.01); A61K 31/5513 (2006.01); A61K 9/00 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/38 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5073 (2013.01); A61K 9/2077 (2013.01); A61K 9/5015 (2013.01); A61K 9/5047 (2013.01); A61K 9/5192 (2013.01); A61K 31/5513 (2013.01);
Abstract
An extended release pharmaceutical composition of Clozapine The extended release composition of Clozapine provides an extended release pharmaceutical composition having Clozapine, a seal coating, an acidic coating, and an extended release coating. The composition is particularly suitable for dispensing a once-a-day solid oral pharmaceutical formulation which releases a therapeutically effective amount of Clozapine over an extended time period.